Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Lactobacillus Reuteri for Androgenetic Alopecia: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Trial

NCT07370519 is registered in ClinicalTrials.gov with Shenzhen People's Hospital as lead sponsor.

NCT NCT07370519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07370519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Lactobacillus Reuteri for Androgenetic Alopecia: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
Shenzhen People's Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
January 25, 2026
Completion date
June 30, 2027
Enrollment
388 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

androgenetic alopecia (aga)